Subcutaneous NAD+: Offers high absorption, is self-administered, and ideal for maintaining NAD+ between IVs
Clinical studies document specific benefits including retinal neuroprotection through neurotrophic factors, improved ocular blood flow enhancing nutrient delivery to photoreceptors, reduced inflammation in age-related macular degeneration, cellular repair accelerating recovery from retinal injury, and potential prevention of progressive vision loss in diabetic retinopathy
Huang X, Huang L, Lu J, Cheng L, Wu D, Li L, et al
Response: We do not believe it is appropriate for all public health reporting measures in the MIPS Promoting Interoperability performance category to be voluntary
DSIP therapy particularly benefits high-performers, athletes, professionals under chronic stress, and anyone prioritizing longevity who recognizes sleep as a foundational health pillar